Hepatic stellate cell damage may lead to decreased plasma ADAMTS13 activity in rats (Q28577463)

31 January 2017

title

Hepatic stellate cell damage may lead to decreased plasma ADAMTS13 activity in rats (English)

1 reference

31 January 2017

Yukio Kume

1

1 reference

31 January 2017

Hitoshi Ikeda

2

1 reference

31 January 2017

Morihiro Inoue

3

1 reference

31 January 2017

Kazuaki Tejima

4

1 reference

31 January 2017

Tomoaki Tomiya

5

1 reference

31 January 2017

Takako Nishikawa

6

1 reference

31 January 2017

Naoko Watanabe

7

1 reference

31 January 2017

Tatsuya Ichikawa

8

1 reference

31 January 2017

Makoto Kaneko

9

1 reference

31 January 2017

Shigeo Okubo

10

1 reference

31 January 2017

Hiromitsu Yokota

11

1 reference

31 January 2017

Masao Omata

12

1 reference

31 January 2017

Kenji Fujiwara

13

1 reference

31 January 2017

Yutaka Yatomi

14

1 reference

31 January 2017

language of work or name

English

0 references

publication date

17 April 2007

1 reference

31 January 2017

1 reference

31 January 2017

volume

581

1 reference

31 January 2017

issue

8

1 reference

31 January 2017

page(s)

1631–1634

1 reference

Upshaw-Schulman syndrome revisited: a concept of congenital thrombotic thrombocytopenic purpura

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.03.029

Deficient activity of von Willebrand factor-cleaving protease in patients with Upshaw-Schulman syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.03.029

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.03.029

Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.03.029

A novel human metalloprotease synthesized in the liver and secreted into the blood: possibly, the von Willebrand factor-cleaving protease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.03.029

Cloning, expression analysis, and structural characterization of seven novel human ADAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.03.029

ADAMTS13 is expressed in hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.03.029

Pyrrolidine dithiocarbamate protects against thioacetamide-induced fulminant hepatic failure in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.03.029

Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.03.029

Intravascular coagulation in acute liver failure in rats and its treatment with antithrombin III

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.03.029

Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.03.029

Plasma ADAMTS13 activity may predict early adverse events in living donor liver transplantation: observations in 3 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.03.029

Human endothelial cells synthesize and release ADAMTS-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.03.029

Apical sorting of ADAMTS13 in vascular endothelial cells and Madin-Darby canine kidney cells depends on the CUB domains and their association with lipid rafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.03.029

Increased ADAMTS-13 proteolytic activity in rat hepatic stellate cells upon activation in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.03.029

Changes in health and disease of the metalloprotease that cleaves von Willebrand factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.03.029

Development of ADAMTS13 inhibitor in a patient with hepatitis C virus-related liver cirrhosis causes thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.03.029

Localization of ADAMTS13 to the stellate cells of human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.03.029

10.1016/J.FEBSLET.2007.03.029

21 January 2018

Identifiers

DOI

1 reference

31 January 2017

1 reference